124 related articles for article (PubMed ID: 2579821)
1. Inhibition of hapten-specific cytotoxic T cell recognition by monoclonal anti-hapten antibodies.
Pircher H; Zinkernagel RM; Hengartner H
Eur J Immunol; 1985 Mar; 15(3):228-35. PubMed ID: 2579821
[TBL] [Abstract][Full Text] [Related]
2. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
Pircher H; Hämmerling G; Hengartner H
Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
[TBL] [Abstract][Full Text] [Related]
3. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
Fujiwara H; Levy RB; Shearer GM
J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated T lymphocyte responses against syngeneic cells modified with amino-reactive hapten (AED-NH2): H-2Dk serves as an element for cell-mediated lympholysis to amino-reactive hapten (AED-NH2)-modified self.
Mizuochi T; Fujiwara H; Takai Y; Hamaoka T
J Immunol; 1985 Feb; 134(2):673-6. PubMed ID: 3871213
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. V. H-2Ld self products are recognized by anti-AED-specific cytotoxic T cells.
Levy RB; Shearer GM
J Immunol; 1983 Apr; 130(4):1506-11. PubMed ID: 6187809
[TBL] [Abstract][Full Text] [Related]
7. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated lympholytic responses against autologous cells modified with haptenic sulfhydryl reagents. I. Effector cells can recognize two distinct classes of hapten-reactive self sites on cell surface proteins.
Levy RB; Shearer GM; Richardson JC; Henkart PA
J Immunol; 1981 Aug; 127(2):523-8. PubMed ID: 6972967
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated lympholysis responses against autologous cells modified with haptenic sulfhydryl reagents. IV. Self-determinants recognized by wild-type anti-H-2Kb and H-2Db-restricted cytotoxic T cells specific for sulfhydryl and amino-reactive haptens are absent in certain H-2 mutant strains.
Levy RB; Shearer GM
J Immunol; 1982 Oct; 129(4):1525-9. PubMed ID: 6180015
[TBL] [Abstract][Full Text] [Related]
10. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.
Weltzien HU; Kempkes B; Jankovic DL; Eichmann K
Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells.
Acha-Orbea H; Zinkernagel RM; Hengartner H
Eur J Immunol; 1985 Jan; 15(1):31-6. PubMed ID: 2578398
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated lympholysis responses against autologous cells modified with haptenic sulfhydryl reagents. II. Analysis of the genetic control and H-2-restricted pattern of cytotoxic responses to sulfhydryl and amino reactive reagents.
Levy RB; Henkart PA; Shearer GM
J Immunol; 1981 Aug; 127(2):529-34. PubMed ID: 6972968
[TBL] [Abstract][Full Text] [Related]
13. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
[TBL] [Abstract][Full Text] [Related]
14. Molecular localization of allogeneic and self determinants recognized by bulk and clonal populations of cytotoxic T cells.
Levy RB; Ozato K; Richardson JC; Bluestone JA
J Immunol; 1985 Feb; 134(2):677-83. PubMed ID: 2578159
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
16. Analysis of true anti-hapten cytotoxic clones in limit dilution microcultures after correction for "anti-self" activity: precursor frequencies, Ly-2 and Thy-1 phenotype, specificity, and statistical methods.
Good MF; Boyd AW; Nossal GJ
J Immunol; 1983 May; 130(5):2046-55. PubMed ID: 6187833
[TBL] [Abstract][Full Text] [Related]
17. The products of transferred H-2 genes express determinants that restrict hapten-specific cytotoxic T cells.
Levy RB; Richardson JC; Margulies DH; Evans GA; Seidman JG; Ozato K
J Immunol; 1983 Jun; 130(6):2514-8. PubMed ID: 6189891
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
[TBL] [Abstract][Full Text] [Related]
20. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
